New Toshiba device tests for 13 different cancer types using just one drop of blood
Toshiba has announced that its scientists have developed a new machine that can test for 13 different types of cancer with 99% accuracy. The machine will only need one drop of blood from the patient and can display results faster than any device on the market. Unfortunately, it will be several years before the device is widely available.
health healthcare toshiba cancer blood
JapanTimesRelated Articles
Apple Maps will soon display COVID-19 testing locations
Apple has launched a portal for hospitals, healthcare providers and businesses to register as a COVID-19 testing location. The testing locations will appear with a red medical glyph icon, and a special banner in the Apple Maps card.
Apple Maps will be able to show information like the place name, the associated healthcare provider, contact phone number and website.
apple healthcare location
Google
Detroit to begin using Abbot Labs' new 5-minute coronavirus test
Detroit is going to become the first city to use the new Abbot Labs 5 minute coronavirus test. The mayor has said that first responders will have access to the test and they will be available within the next 24 hours. The test requires very little equipment and can produce results faster than any other available method.
test health economy death coronavirus quarantine lab money detroit abbot-labs
TechCrunch
Video Conferencing apps experience record levels of demand
Due to the lockdown that has taken place in numerous countries across the planet, more and more people are working via video conference apps and software. Since people are unable to leave their homes, video conference apps have gotten 62 million new downloads this week, a new world record.
internet health economy death coronavirus quarantine money zoom skype video-conference voice-chat communication
TechCrunch
Johnson & Johnson to fund $1 billion coronavirus vaccine research
Pharmaceutical giant Johnson & Johnson has partnered up with the US Biomedical Advanced Research and Development Authority to fun $1 billion's worth of coronavirus vaccine and treatment research. The company intends to provide 1 billion doses of the vaccine worldwide and will likely start clinical trials by September. They intend to have it ready by 2021.
health research economy vaccine death coronavirus quarantine money covid-19 johnson-johnson
TechCrunch